Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Inulin-type fructan improves diabetic phenotype and gut microbiota profiles inΒ rats. β
Go to Publication β
PeerJ (PeerJ ) Vol: 6 Issue Pages: e4446 Pub: 2018 Epub: 2018 Mar 1 Authors Zhang Q , Yu H , Xiao X , Hu L , Xin F , Yu X , |
|
|
Immunomodulatory effects of inulin and its intestinal metabolites. β
Go to Publication β
Frontiers in immunology (Front Immunol ) Vol: 14 Issue Pages: 1224092 Pub: 2023 Epub: 2023 Aug 10 Authors Sheng W , Ji G , Zhang L , |
|
|
Immunomodulatory effects of inulin and its intestinal metabolites. β
Go to Publication β
Frontiers in immunology (Front Immunol ) Vol: 14 Issue Pages: 1224092 Pub: 2023 Epub: 2023 Aug 10 Authors Sheng W , Ji G , Zhang L , |
|
|
Inulin intervention attenuates hepatic steatosis in rats via modulating gut microbiota and maintaining intestinal barrier function. β
Go to Publication β
Food research international (Ottawa, Ont.) (Food Res Int ) Vol: 163 Issue Pages: 112309 Pub: 2023 Jan Epub: 2022 Dec 7 Authors Yang Z , Su H , Lv Y , Tao H , Jiang Y , Ni Z , Peng L , Chen X , |
|
|
Dietary Inulin Regulated Gut Microbiota and Improved Neonatal Health in a Pregnant Sow Model. β
Go to Publication β
Frontiers in nutrition (Front Nutr ) Vol: 8 Issue Pages: 716723 Pub: 2021 Epub: 2021 Aug 9 Authors Li H , Ma L , Zhang L , Liu N , Li Z , Zhang F , Liu X , Ma X , |
|
|
Effects of a diet based on inulin-rich vegetables on gut health and nutritional behavior in healthy humans. β
Go to Publication β
The American journal of clinical nutrition (Am J Clin Nutr ) Vol: 109 Issue 6 Pages: 1683-1695 Pub: 2019 Jun 1 Epub: Authors Hiel S , Bindels LB , Pachikian BD , Kalala G , Broers V , Zamariola G , Chang BPI , Kambashi B , Rodriguez J , Cani PD , Neyrinck AM , Thissen JP , Luminet O , Bindelle J , Delzenne NM , |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
